Costello Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Costello Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37	Closed	-$3.07K	–	704
2025 Q2	$3.07K	Hold	37	–	–	﹤0.01%	605
2025 Q1	$3K	Hold	37	–	–	﹤0.01%	590
2024 Q4	$3.33K	Hold	37	–	–	﹤0.01%	175
2024 Q3	$3.66K	Hold	37	–	–	﹤0.01%	173
2024 Q2	$3.43K	Hold	37	–	–	﹤0.01%	157
2024 Q1	$3.51K	Hold	37	–	–	﹤0.01%	164
2023 Q4	$3.3K	Hold	37	–	–	﹤0.01%	165
2023 Q3	$2.7K	Hold	37	–	–	﹤0.01%	178
2023 Q2	$3.08K	Hold	37	–	–	﹤0.01%	173
2023 Q1	$2.82K	Hold	37	–	–	﹤0.01%	188
2022 Q4	$3.07K	Hold	37	–	–	﹤0.01%	184
2022 Q3	$3K	Hold	37	–	–	﹤0.01%	191
2022 Q2	$3K	Hold	37	–	–	﹤0.01%	203
2022 Q1	$3K	Hold	37	–	–	﹤0.01%	214
2021 Q4	$4K	Hold	37	–	–	﹤0.01%	209
2021 Q3	$5K	Hold	37	–	–	﹤0.01%	194
2021 Q2	$5K	Sell	37 -45	-55%	-$5.92K	﹤0.01%	196
2021 Q1	$11K	Hold	82	–	–	0.01%	190
2020 Q4	$12K	Hold	82	–	–	0.01%	173
2020 Q3	$9K	Hold	82	–	–	0.01%	173
2020 Q2	$9K	Buy	+82	New	+$8.08K	0.01%	163

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Costello Asset Management's XBI Position: Q3 2025 in Review

Costello Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 37 shares — an estimated $3.07K sold.

Costello Asset Management first reported a position in XBI in Q2 2020 and held it in 21 quarters. The position peaked at $12K in Q4 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

Costello Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
Costello Asset Management sold 37 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $3.07K.
Costello Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 21 quarters.
Costello Asset Management's State Street SPDR S&P Biotech ETF position peaked at $12K in Q4 2020.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Costello Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.